<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00368147</url>
  </required_header>
  <id_info>
    <org_study_id>2002027-01H</org_study_id>
    <nct_id>NCT00368147</nct_id>
  </id_info>
  <brief_title>Access Creation for Hemodialysis: Association With Structural Changes of the Heart</brief_title>
  <official_title>Access Creation for Hemodialysis: Potential Contribution to Left Ventricular Remodelling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Kidney Foundation of Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the creation of a fistula or a graft plays a
      role in the development of heart disease for patients undergoing hemodialysis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with end stage renal disease are at 18-20 times greater risk of dying from
      cardiovascular disease as the general population. Both traditional and non-traditional
      cardiovascular risk factors are thought to be important. Of the non-tradtional cardiovascular
      risk factors, creation of an arteriovenous fistula or graft for the purposes of a blood
      access for hemodialysis may contribute to an elevation in BNP and left ventricular
      hypertrophy - both factors that have been associated with an increased risk of mortality
      Prior to access creation and at one month and one year post access creation - samples for BNP
      will be collected Prior to access creation and at one year post access creation -
      echocardiography will be performed
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2002</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">84</enrollment>
  <condition>Arteriovenous Fistula</condition>
  <condition>Arteriovenous Graft</condition>
  <condition>Left Ventricular Hypertrophy</condition>
  <condition>Brain Natriuretic Peptide</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: 1)Hemodialysis 2)high risk for heart failure (DM, age&amp;gt;50, and/or
        systolic dysfunction) 3) first arteriovenous fistula/graft 4) informed consent 5)
        technically adequate echocardiogram 6) stable hgb(&amp;gt;100) 7) stable mineral metabolism
        (normal calcium, phosphate &amp;lt;2.1mmol/L, PTH&amp;gt;50pmol/L)

        Exclusion Criteria: 1)Expected survival &amp;lt;1 year 2) Expected to get a living donor
        transplant in one year 3)primary access failure 4) ARF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deborah Zimmerman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Hospital Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Heatlh Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2006</study_first_submitted>
  <study_first_submitted_qc>August 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2006</study_first_posted>
  <last_update_submitted>February 19, 2009</last_update_submitted>
  <last_update_submitted_qc>February 19, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2009</last_update_posted>
  <responsible_party>
    <name_title>Deborah Zimmerman</name_title>
    <organization>Kidney Research Centre</organization>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Arteriovenous Fistula</keyword>
  <keyword>Arteriovenous Graft</keyword>
  <keyword>Left Ventricular Hypertrophy</keyword>
  <keyword>Brain Natriuretic Peptide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Hypertrophy, Left Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

